Known Medicine Patents

Patent portfolio assigned to Known Medicine (verified via public assignee records). Estimated patent count: 1. Salt Lake City micro-tumor / 3D organoid + ML cancer drug-response platform (YC S20); acquired by Pathos AI in 2023. CBInsights shows 1 filed patent ('Three-dimensional cell culture systems and methods'). Competitors are same-space oncology/organoid drug-response firms; no direct competitor list on CBInsights so drawn from oncology AI roundup.